Induction of β3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway

Molecular and Cellular Biology

Volumn 21, Issue 9, 2001, Pages 3192-3205

  Woods, D ^a   Cherwinski, H ^a   Venetsanakos, E ^a   Bhat, A ^a   Gysin, S ^a   Humbert, M ^a   Bray, P F ^a   Saylor, V L ^a   McMahon, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN; RAS PROTEIN; SCLEROPROTEIN; FIBRINOGEN RECEPTOR; LEUKOCYTE ANTIGEN; MAP2K1 PROTEIN, HUMAN; MAP2K1 PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROTEIN SERINE THREONINE KINASE; VITRONECTIN RECEPTOR;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER INVASION; CELL STRAIN 3T3; CELL SURFACE; CONTROLLED STUDY; GENE EXPRESSION SYSTEM; GENE INDUCTION; IMMEDIATE EARLY GENE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; STAINING; ANIMAL; CELL MEMBRANE; CELL STRAIN K 562; DIMERIZATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; ANTIGENS, CD; CELL MEMBRANE; DIMERIZATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HUMANS; INTEGRIN BETA3; K562 CELLS; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PLATELET MEMBRANE GLYCOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; RECEPTORS, VITRONECTIN;

EID: 0034744538     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.9.3192-3205.2001     Document Type: Article

References (91)

1. Integrin distribution in malignant melanoma: Association of the beta 3 subunit with tumor progression
2. Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation
3. Oncogenes in melanomas
4. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src
5. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family
6. Non-nuclear oncogenes and the regulation of gene expression in transformed cells
7. Ras oncogenes in human cancer: A review
8. Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1
9. Induction of the angiogenic phenotype by Hox D3
10. Requirement of vascular integrin alpha v beta 3 for angiogenesis
11. Anti-integrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin
12. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
13. Increasing complexity of Ras signaling
14. Integrin-mediated signal transduction pathways
15. Molecular genetics of human cancer predisposition and progression
16. Phosphatidylinositol 3-kinase regulates raf1 through pak phosphorylation of serine 338
17. Genomic analysis of metastasis reveals an essential role for RhoC
18. Integrin-mediated signals regulated by members of the rho family of GTPases
19. 1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation
20. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
21. Integrins and signal transduction
22. Genomics and array technology
23. A synthetic inhibitor of the mitogen-activated protein kinase cascade
24. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells
25. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
26. Requirement of the NPXY motif in the integrin beta 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo
27. Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation
28. Genetics and malignant progression of human brain tumours
29. Integrin expression in human melanoma cells with differing invasive and metastatic properties
30. Integrin signaling
31. Enzymatic and antisense effects of a specific anti-Ki-ras ribozyme in vitro and in cell culture
32. Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells
33. Stimulation of protein tyrosine phosphorylation by the B-lymphocyte antigen receptor
34. RhoE regulates actin cytoskeleton organization and cell migration
35. Dissection of ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: Evidence for a potential novel pathway
36. Targeted antiangiogenic therapy for cancer using Vitaxin: A humanized monoclonal antibody to the integrin alphavbeta3
37. Induced expression of Rnd3 is associated with transformation of polarized epithelial cells by the Raf-MEK-extracellular signal-regulated kinase pathway
38. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
39. Suppression of integrin activation: A novel function of a Ras/Raf- initiated MAP kinase pathway
40. Integrins: Versatility, modulation, and signaling in cell adhesion
41. Genetic manipulation of vascular adhesion molecules in mice
42. The transcriptional program in the response of human fibroblasts to serum
43. Adhesion molecules in cancer: The role of integrins
44. Role of Ras/ERK-dependent pathway in the erythroid differentiation of K562 cells
45. The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: Lysine 7 is a critical determinant
46. Regulation of c-myc expression by Ras/Raf signalling
47. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation
48. Construction and characterization of a conditionally active version of the serine/threonine kinase Akt
49. Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function
50. Differential expression of alphav integrins in K1735 melanoma cells
51. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins
52. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain
53. Identification of immediate-early gene targets of the Raf-1 serine/threonine protein kinase using an estradiol-dependent fusion protein, delta Raf-1:ER
54. Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1
55. Rapid induction of heparin-binding epidermal growth factor/diphtheria toxin receptor expression by Raf and Ras oncogenes
56. Sp1 phosphorylation by Erk 2 stimulates DNA binding
57. Identification and in vivo efficacy of small-molecule antagonists of integrin alphavbeta3 (the vitronectin receptor)
58. Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB
59. Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three- dimensional dermal collagen
60. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
61. Human melanoma cells derived from lymphatic metastases use integrin alpha v beta 3 to adhere to lymph node vitronectin
62. A new member of the Rho family, Rnd1, promotes disassembly of actin filament structures and loss of cell adhesion
63. Production of high-titer helper-free retroviruses by transient transfection
64. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells
65. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway
66. Opposing effects of Ras on p53: Transcriptional activation of mdm2 and induction of p19ARF
67. Fibronectin and its integrin receptors in cancer
68. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation
69. Inhibition of platelet-derived growth factor-and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing ΔRaf-1:ER, an estradiol-regulated form of Raf-1
70. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase
71. Role of alpha V integrins and vitronectin in human melanoma cell growth
72. Role of the cytoskeletal protein paxillin in oncogenesis
73. In vivo functions of integrins: Lessons from null mutations in mice
74. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras
75. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics
76. Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor
77. Activation of human raf transforming genes by deletion of normal amino- terminal coding sequences
78. The role of integrins in the malignant phenotype of gliomas
79. Integrins and cancer
80. Tumor angiogenesis and the role of vascular cell integrin alphavbeta3
81. Isolation and characterization of a TATA-less promoter for the human beta 3 integrin gene
82. Signaling pathways in Ras-mediated tumorigenicity and metastasis
83. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase
84. Multiple Ras functions can contribute to mammalian cell transformation
85. The human integrin beta3 gene is 63 kb and contains a 5′-UTR sequence regulating expression
86. Overlapping and specific functions of braf and craf-1 proto-oncogenes during mouse embryogenesis
87. Endothelial apoptosis in Braf-deficient mice
88. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1
89. Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2
90. Senescence of human fibroblasts induced by oncogenic Raf
91. Rho family proteins and Ras transformation: The RHOad less traveled gets congested